Pharmacogenomics Flashcards Preview

Pharmacology > Pharmacogenomics > Flashcards

Flashcards in Pharmacogenomics Deck (23)
Loading flashcards...
1
Q

What is pharmacogenomics?

A

How genetics affects response to drugs

2
Q

In the normal curve, what groups are on the far left?

A

Poor Metabolizers

Excellent Responders

3
Q

In the normal curve, what groups are in the middle?

A

Good Metabolizers

Normal Responders

4
Q

In the the normal curve, what groups are on the far right?

A

Ultra Metabolizers

Poor Responders

5
Q

Mutation

A

It is an alteration of DNA sequence that is present only rarely in the population

6
Q

Polymorphism

A

It is an alteration of DNA sequence that is present commonly in the population (>1% of the population)
- difference between mutation and polymorphism lies only in the frequency of occurrence

7
Q

What is a SNP?

A

Single Nucleotide Polymorphism (SNP) - a polymorphism due to a change in a single nucleotide

8
Q

ADR

A

Adverse Drug Reaction

9
Q

What are the two genetic factors that affect an individuals response to a drug?

A
  • Drug Metabolism Enzymes

- Drug Receptor Enzymes

10
Q

What part of metabolism is CYP2D6 a part of and what types of drugs does it affect?

A

Phase I Enzyme

Debrisoquine and sparteine

Anti-depressants (Tricyclics)
Anti-arrhythmics,
Beta-blockers
Neuroleptics

11
Q

What part of metabolism is CYP2C9 a part of and what types of drugs does it affect?

A

Phase I Enzyme

Warfarin - mutations can cause danger for excessive bleeding

Tolbutamide
Phenytoin
Nonsteroidal anti-inflammatories

12
Q

What do mutations in VKORC1 affect?

A

Warfarin as it is a key warfarin drug target

13
Q

What part of metabolism is CYP2C19 a part of and what types of drugs does it affect?

A

Phase I Enzyme

Clopidogrel (Plavix) - prodrug converted to active metabolite and patients with CYP2C19 are unresponsive to clopidogrel

14
Q

What part of metabolism is N-Acetyltransferase 2 a part of and what types of drugs does it affect?

A

Phase II Enzyme

There is a slow acetylator phenotype that causes poor conjugation leading to the danger of increased toxicity.

15
Q

Directly hereditary diseases

A

Diseases whose origin is in the genome itself.

Examples:

Huntington’s Chorea (autosomal dominant) 
Cystic fibrosis (autosomal recessive)
16
Q

Environmentally dependent diseases

A

Have a genetic disease that is influenced by genetic factors that will increase a person’s susceptibility to diseases if they are exposed to the proper environments.

Examples:

Type II diabetes mellitus
Parkinson’s disease
Hypertension – 50 different genes
Alzheimer’s disease (late-onset; Cholesterol genes – ApoE) 
Cancer
17
Q

What are pharmacogenomic therapies and what are examples of them?

A

Hormones can now be routinely synthesized in the laboratory in mass production – recombinant protein hormones used as therapeutic agents.

Example: Epogen (erythropoietin) - used to treat chronic kidney failure on dialysis

18
Q

How can pharmacogenomics be useful in clinical trials?

A

Use pharmacogenetic data to determine who would be good responders

19
Q

What population responds well to hydralazine?

A

African Americans

20
Q

PCR

A

Polymerase Chain Reaction

-Used for DNA amplification

21
Q

FISH

A

Fluorescent in situ Hybridization

-Identify gene location on chromosome

22
Q

How was Her2-Neu used to individualize cancer treatment?

A

Patients with Her2 amplification are treated with Herceptin (trastuzumab)

23
Q

How is Bcr-Abl used to individualize leukemia treatment?

A

Gleevec (imatinib) - inhibits Bcr-Abl tyrosine kinase and is used on patients with abnormal karyotype showing a chromosomal rearrangement due to a translocation
designated t(9;22)

Decks in Pharmacology Class (74):